MAP2K5 and neoplasm: Importantly, aberrant MEK5/ERK5 signaling has been reported in several types of human cancer, including colon cancer [11, 12], and its association with increased cell proliferation, tumor angiogenesis and metastasis is becoming increasingly recognized [13, 14].